Regulated companies are moving to Cloud solutions to store data, improving their performance and capability, while keeping a careful GxP oriented.
EMA has recommended the suspension of around 100 generic drugs for Data Integrity and Reliability issues, with the consequence of repeating the.
To guarantee high quality of standards in production, every investment in the medical cannabis production should take into consideration a.
Technologically up to date Greenhouse facilities, that respects the standards for medical cannabis production, ensure high productivity and.
The Point of Care is a new approach for which drugs production sites should be as much close as possible to patients, to reduce the product lead.
Industry 4.0 affects the whole industrial production, tobacco products included, bringing new challenges and improving production capacity and.
Project Orbis and other collaborative projects are shaping the future of Regulatory Affairs, helping patients by getting products to market in.
A recent bill from the US Government closed the regulation loophole for synthetic nicotine, making producers review their strategy to access the.
Medical Cannabis is going through a period of change in terms of culture and regulations, with countries that are now drafting or issuing new bills.
Health Authorities collaborative projects in Regulatory Affairs are getting many attentions lately because of their speed in getting products to.
